Chapter 1: Introduction

1.1. Report Description
1.2. Key Benefits For Stakeholders
1.3. Research Methodology

1.3.1. Secondary Research
1.3.2. Primary Research
1.3.3. Analyst Tools & Models

Chapter 2: Executive Summary

2.1. Cxo Perspective

Chapter 3: Market Overview

3.1. Market Definition And Scope
3.2. Porter'S Five Forces Analysis
3.3. Top Player Positioning
3.4. Market Dynamics

3.4.1. Drivers

3.4.1.1. Increase Use of Opioids In Pain Management
3.4.1.2. Upsurge In Consumption of Opioids In Developing Economies

3.4.2. Restraints

3.4.2.1. Implementation of Stringent Government Regulation Toward Vigorous Prescription
3.4.2.2. Opioid Crisis Across The Globe

3.4.3. Impacting Factors

Chapter 4: Opioids Market, By Product

4.1. Overview

4.1.1. Market Size And Forecast, By Product Type

4.2. Codeine

4.2.1. Key Market Trends
4.2.2. Market Size And Forecast, By Region
4.2.3. Market Analysis, By Country

4.3. Fentanyl

4.3.1. Key Market Trends
4.3.2. Market Size And Forecast, By Region
4.3.3. Market Analysis, By Country

4.4. Oxycodone

4.4.1. Key Market Trends
4.4.2. Market Size And Forecast, By Region
4.4.3. Market Analysis, By Country

4.5. Methadone

4.5.1. Key Market Trends
4.5.2. Market Size And Forecast
4.5.3. Market Analysis, By Country

4.6. Morphine

4.6.1. Key Market Trends
4.6.2. Market Size And Forecast
4.6.3. Market Analysis, By Country

4.7. Hydrocodone

4.7.1. Key Market Trends
4.7.2. Market Size And Forecast
4.7.3. Market Analysis, By Country

4.8. Others

4.8.1. Key Market Trends
4.8.2. Market Size And Forecast
4.8.3. Market Analysis, By Country

Chapter 5: Opioids Market, By Application

5.1. Overview

5.1.1. Market Size And Forecast, By Application

5.2. Pain Management

5.2.1. Market Size And Forecast, By Region
5.2.2. Market Analysis, By Country

5.2.2.1. Neuropathic Pain

5.2.2.1.1. Market Size And Forecast

5.2.2.2. Migraine

5.2.2.2.1. Market Size And Forecast

5.2.2.3. Back Pain

5.2.2.3.1. Market Size And Forecast

5.2.2.4. Osteoarthritis Pain

5.2.2.4.1. Market Size And Forecast

5.2.2.5. Cancer Pain

5.2.2.5.1. Market Size And Forecast

5.2.2.6. Others

5.2.2.6.1. Market Size And Forecast

5.3. Cough Treatment

5.3.1. Market Size And Forecast, By Region
5.3.2. Market Analysis, By Country

5.4. Diarrhea Treatment

5.4.1. Market Size And Forecast, By Region
5.4.2. Market Analysis, By Country

Chapter 6: Opioids Market, By Region

6.1. Overview

6.1.1. Market Size And Forecast

6.2. North America

6.2.1. Key Market Trends
6.2.2. Market Size And Forecast, By Product
6.2.3. Market Size And Forecast, By Application
6.2.4. Market Size And Forecast, By Country

6.2.4.1. U.S. Market Size And Forecast, By Product
6.2.4.2. U.S. Market Size And Forecast, By Application
6.2.4.3. Canada Market Size And Forecast, By Product
6.2.4.4. Canada Market Size And Forecast, By Application
6.2.4.5. Mexico Market Size And Forecast, By Product
6.2.4.6. Mexico Market Size And Forecast, By Application

6.3. Europe

6.3.1. Key Market Trends
6.3.2. Market Size And Forecast, By Product
6.3.3. Market Size And Forecast, By Application
6.3.4. Market Size And Forecast, By Country

6.3.4.1. France Market Size And Forecast, By Product
6.3.4.2. France Market Size And Forecast, By Application
6.3.4.3. Uk Market Size And Forecast, By Product
6.3.4.4. Uk Market Size And Forecast, By Application
6.3.4.5. Germany Market Size And Forecast, By Product
6.3.4.6. Germany Market Size And Forecast, By Application
6.3.4.7. Spain Market Size And Forecast, By Product
6.3.4.8. Spain Market Size And Forecast, By Application
6.3.4.9. Rest of Europe Market Size And Forecast, By Product
6.3.4.10. Rest of Europe Market Size And Forecast, By Application

6.4. Asia-Pacific

6.4.1. Key Market Trends
6.4.2. Market Size And Forecast, By Product
6.4.3. Market Size And Forecast, By Application
6.4.4. Market Size And Forecast, By Country

6.4.4.1. Japan Market Size And Forecast, By Product
6.4.4.2. Japan Market Size And Forecast, By Application
6.4.4.3. China Market Size And Forecast, By Product
6.4.4.4. China Market Size And Forecast, By Application
6.4.4.5. India Market Size And Forecast, By Product
6.4.4.6. India Market Size And Forecast, By Application
6.4.4.7. Australia Market Size And Forecast, By Product
6.4.4.8. Australia Market Size And Forecast, By Application
6.4.4.9. Taiwan Market Size And Forecast, By Product
6.4.4.10. Taiwan Market Size And Forecast, By Application
6.4.4.11. South Korea Market Size And Forecast, By Product
6.4.4.12. South Korea Market Size And Forecast, By Application
6.4.4.13. Rest of Asia-Pacific Market Size And Forecast, By Product
6.4.4.14. Rest of Asia-Pacific Market Size And Forecast, By Application

6.5. Lamea

6.5.1. Key Market Trends
6.5.2. Market Size And Forecast, By Product
6.5.3. Market Size And Forecast, By Application
6.5.4. Market Size And Forecast, By Country

6.5.4.1. Brazil Market Size And Forecast, By Product
6.5.4.2. Brazil Market Size And Forecast, By Application
6.5.4.3. Turkey Market Size And Forecast, By Product
6.5.4.4. Turkey Market Size And Forecast, By Application
6.5.4.5. Saudi Arabia Market Size And Forecast, By Product
6.5.4.6. Saudi Arabia Market Size And Forecast, By Application
6.5.4.7. South Africa Market Size And Forecast, By Product
6.5.4.8. South Africa Market Size And Forecast, By Application
6.5.4.9. Rest of Lamea Market Size And Forecast, By Product
6.5.4.10. Rest of Lamea Market Size And Forecast, By Application

Chapter 7: Compony Profiles

7.1. Allergan Plc.

7.1.1. Company Overview
7.1.2. Company Snapshot
7.1.3. Operating Business Segments
7.1.4. Product Portfolio
7.1.5. Business Performance

7.2. Boehringer Ingelheim Group

7.2.1. Company Overview
7.2.2. Company Snapshot
7.2.3. Operating Business Segments
7.2.4. Product Portfolio
7.2.5. Business Performance

7.3. Endo Pharmaceuticals Inc. (Par Pharmaceutical)

7.3.1. Company Overview
7.3.2. Company Snapshot
7.3.3. Operating Business Segments
7.3.4. Product Portfolio
7.3.5. Business Performance

7.4. Johnson & Johnson (Janssen Global Services, Llc)

7.4.1. Company Overview
7.4.2. Company Snapshot
7.4.3. Operating Business Segments
7.4.4. Product Portfolio
7.4.5. Business Performance

7.5. Mallinckrodt Plc (Specgx Llc)

7.5.1. Company Overview
7.5.2. Company Snapshot
7.5.3. Operating Business Segments
7.5.4. Product Portfolio
7.5.5. Business Performance

7.6. Pfizer Inc.

7.6.1. Company Overview
7.6.2. Company Snapshot
7.6.3. Operating Business Segments
7.6.4. Product Portfolio
7.6.5. Business Performance

7.7. Purdue Pharma L.P.

7.7.1. Company Overview
7.7.2. Company Snapshot
7.7.3. Operating Business Segments
7.7.4. Product Portfolio
7.7.5. Business Performance

7.8. Sanofi S.A.

7.8.1. Company Overview
7.8.2. Company Snapshot
7.8.3. Operating Business Segments
7.8.4. Product Portfolio
7.8.5. Business Performance

7.9. Sun Pharmaceutical Industries Ltd.

7.9.1. Company Overview
7.9.2. Company Snapshot
7.9.3. Operating Business Segments
7.9.4. Product Portfolio
7.9.5. Business Performance

7.10. Teva Pharmaceutical Industries Limited

7.10.1. Company Overview
7.10.2. Company Snapshot
7.10.3. Operating Business Segments
7.10.4. Product Portfolio
7.10.5. Business Performance